Allergan (NYSE:AGN) reported third quarter earnings that beat analyst's expectations on Tuesday and revenue that topped forecasts.
The firm reported earnings per share of $4.25 on revenue of $3.91B. Analysts polled by anticipated EPS of $4.03 on revenue of $3.89B. That compared to EPS of $4.15 on revenue of $4.03B in the same period a year earlier. The company had reported EPS of $4.42 on revenue of $4.1B in the previous quarter.
For the year, Allergan shares are up 6.25%, outperforming the S&P 500 which is down 1.58% year to date.
Allergan follows other major Healthcare sector earnings this month
On October 16, J&J (NYSE:JNJ) reported third quarter EPS of $2.05 on revenue of $20.35B, compared to forecasts of EPS of $2.03 on revenue of $20.05B.
Novartis ADR earnings beat analyst's expectations on October 18, with third quarter EPS of $1.32 on revenue of $12.78B. analysts expected EPS of $1.3 on revenue of $12.94B
Stay up-to-date on all of the upcoming earnings reports by visiting 's earnings calendar
